BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30875258)

  • 1. Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration.
    Mishra S; Joshi S; Ward JE; Buys EP; Mishra D; Mishra D; Morgado I; Fisch S; Lavatelli F; Merlini G; Dorbala S; MacRae CA; Liao R
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1158-H1166. PubMed ID: 30875258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.
    Mishra S; Guan J; Plovie E; Seldin DC; Connors LH; Merlini G; Falk RH; MacRae CA; Liao R
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H95-103. PubMed ID: 23624626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.
    Guan J; Mishra S; Shi J; Plovie E; Qiu Y; Cao X; Gianni D; Jiang B; Del Monte F; Connors LH; Seldin DC; Lavatelli F; Rognoni P; Palladini G; Merlini G; Falk RH; Semigran MJ; Dec GW; Macrae CA; Liao R
    Basic Res Cardiol; 2013 Sep; 108(5):378. PubMed ID: 23982491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis.
    Joshi S; Evangelisti A; Liao R; Alexander KM
    Curr Cardiol Rep; 2020 Jan; 22(1):1. PubMed ID: 31932992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity.
    Guan J; Mishra S; Qiu Y; Shi J; Trudeau K; Las G; Liesa M; Shirihai OS; Connors LH; Seldin DC; Falk RH; MacRae CA; Liao R
    EMBO Mol Med; 2014 Nov; 6(11):1493-507. PubMed ID: 25319546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report.
    Shin JT; Ward JE; Collins PA; Dai M; Semigran HL; Semigran MJ; Seldin DC
    Amyloid; 2012 Dec; 19(4):191-6. PubMed ID: 23126591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.
    Imperlini E; Gnecchi M; Rognoni P; Sabidò E; Ciuffreda MC; Palladini G; Espadas G; Mancuso FM; Bozzola M; Malpasso G; Valentini V; Palladini G; Orrù S; Ferraro G; Milani P; Perlini S; Salvatore F; Merlini G; Lavatelli F
    Sci Rep; 2017 Nov; 7(1):15661. PubMed ID: 29142197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Cardiac Amyloidosis.
    Morfino P; Aimo A; Franzini M; Vergaro G; Castiglione V; Panichella G; Limongelli G; Emdin M
    Heart Fail Clin; 2024 Jul; 20(3):261-270. PubMed ID: 38844297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical characterization of a lambda I amyloid protein isolated from formalin-fixed and paraffin-embedded tissue sections.
    Yazaki M; Liepnieks JJ; Callaghan J; Connolly CE; Benson MD
    Amyloid; 2004 Mar; 11(1):50-5. PubMed ID: 15185499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
    Halushka MK; Eng G; Collins AB; Judge DP; Semigran MJ; Stone JR
    J Cardiovasc Transl Res; 2015 Jun; 8(4):264-8. PubMed ID: 25925232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lambda light-chain deposition presenting with predominant cardiac involvement.
    Garton MJ; Walton S; Ewen SW
    Postgrad Med J; 1993 Jul; 69(813):588-91. PubMed ID: 8415352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light Chain Amyloidosis-Induced Autophagy Is Mediated by the Foxo3a/Beclin-1 Pathway in Cardiomyocytes.
    Zhang Y; Yu W; Chang W; Wang M; Zhang L; Yu F
    Lab Invest; 2023 Feb; 103(2):100001. PubMed ID: 37039144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
    Kimura K; Tsukamoto S; Miyazaki K; Kawajiri-Manako C; Ishii A; Rahmutulla B; Fukuyo M; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Matsusaka K; Sanada M; Yokote K; Kaneda A; Ishida T; Suzuki K; Nakaseko C; Sakaida E
    Exp Hematol; 2021 Sep; 101-102():34-41.e4. PubMed ID: 34411686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline decreases amyloidogenic light chain-induced autophagy in isolated primary cardiac myocytes.
    Valero-Muñoz M; Wilson RM; Bretón-Romero R; Croteau D; Seldin DC; Sam F
    Int J Cardiol; 2020 Dec; 321():133-136. PubMed ID: 32682005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
    Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.
    Ward JE; Ren R; Toraldo G; Soohoo P; Guan J; O'Hara C; Jasuja R; Trinkaus-Randall V; Liao R; Connors LH; Seldin DC
    Blood; 2011 Dec; 118(25):6610-7. PubMed ID: 21998211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential light chain S195 phosphorylation is required for cardiac adaptation under physical stress.
    Scheid LM; Mosqueira M; Hein S; Kossack M; Juergensen L; Mueller M; Meder B; Fink RH; Katus HA; Hassel D
    Cardiovasc Res; 2016 Jul; 111(1):44-55. PubMed ID: 27013636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsecretory immunoglobulin-derived amyloidosis of the heart: diagnosis by immunohistochemistry of the endomyocardium.
    Chau EM; Cheung SC; Chow SL; Fu KH
    Clin Cardiol; 1997 May; 20(5):494-6. PubMed ID: 9134284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.